QUESTCOR PHARMACEUTICALS INC Operating Income
QUESTCOR PHARMACEUTICALS INC reported Operating Income of $147.76 million for the 3-month period ending 2014-06-30, per its 10-Q filed 2014-07-25.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2014-07-25
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-06-30 was $147.76M, a 43.36% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for the quarter ending 2014-03-31 was $113.02M, a 95.39% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-12-31 was $136.33M, a 43.87% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for the quarter ending 2013-09-30 was $142.09M, a 70.32% increase year-over-year.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for fiscal 2013 was $439.84M, a 48.33% increase from fiscal 2012.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for fiscal 2012 was $296.53M, a 162.14% increase from fiscal 2011.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for fiscal 2011 was $113.12M, a 110.10% increase from fiscal 2010.
- QUESTCOR PHARMACEUTICALS INC operating income (loss) for fiscal 2010 was $53.84M, a 30.62% increase from fiscal 2009.
| Period end | Operating Income (Loss) 2 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2014-06-30 | $147.76M 10-Q · filed 2014-07-25 | $261.63M 10-Q · filed 2014-07-25 | $397.12M derived: sum of 3 quarters · filed 2014-07-25 | $539.20M derived: sum of 4 quarters · filed 2014-07-25 | ||
| 2014-03-31 | $113.02M 10-Q · filed 2014-04-29 | $249.35M derived: sum of 2 quarters · filed 2014-04-29 | $391.44M derived: sum of 3 quarters · filed 2014-04-29 | $494.51M derived: sum of 4 quarters · filed 2014-07-25 | ||
| 2013-12-31 | $136.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $278.42M derived: sum of 2 quarters · filed 2014-02-26 | $381.49M derived: sum of 3 quarters · filed 2014-07-25 | $439.84M 10-K · filed 2014-02-26 | ||
| 2013-09-30 | $142.09M 10-Q · filed 2013-10-30 | $245.16M derived: sum of 2 quarters · filed 2014-07-25 | $303.50M 10-Q · filed 2013-10-30 | $397.76M derived: sum of 4 quarters · filed 2014-07-25 | ||
| 2013-06-30 | $103.07M 10-Q · filed 2014-07-25 | $161.42M 10-Q · filed 2014-07-25 | $255.68M derived: sum of 3 quarters · filed 2014-07-25 | $339.10M derived: sum of 4 quarters · filed 2014-07-25 | ||
| 2013-03-31 | $57.84M 10-Q · filed 2014-04-29 | $58.35M 10-Q · filed 2013-05-02 | $152.60M derived: sum of 2 quarters · filed 2014-04-29 | $236.03M derived: sum of 3 quarters · filed 2014-04-29 | $297.04M derived: sum of 4 quarters · filed 2014-04-29 | |
| 2012-12-31 | $94.76M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $178.18M derived: sum of 2 quarters · filed 2014-02-26 | $239.19M derived: sum of 3 quarters · filed 2014-02-26 | $296.53M 10-K · filed 2014-02-26 | ||
| 2012-09-30 | $83.42M 10-Q · filed 2013-10-30 | $144.43M derived: sum of 2 quarters · filed 2013-10-30 | $201.77M 10-Q · filed 2013-10-30 | $244.50M derived: sum of 4 quarters · filed 2014-02-26 | ||
| 2012-09-01 | $83.42M 10-Q · filed 2012-10-23 | |||||
| 2012-06-30 | $61.01M 10-Q · filed 2013-07-31 | $118.35M 10-Q · filed 2013-07-31 | $161.08M derived: sum of 3 quarters · filed 2014-02-26 | $194.68M derived: sum of 4 quarters · filed 2014-02-26 | ||
| 2012-03-31 | $57.34M 10-Q · filed 2013-05-02 | $100.07M derived: sum of 2 quarters · filed 2014-02-26 | $133.67M derived: sum of 3 quarters · filed 2014-02-26 | $154.09M derived: sum of 4 quarters · filed 2014-02-26 | ||
| 2011-12-31 | $42.74M derived: 10-K 12 month − 10-Q/A 9 month · filed 2014-02-26 | $76.34M derived: sum of 2 quarters · filed 2014-02-26 | $96.76M derived: sum of 3 quarters · filed 2014-02-26 | $113.12M 10-K · filed 2014-02-26 | ||
| 2011-09-30 | $33.60M 10-Q/A · filed 2012-10-25 | $54.02M derived: sum of 2 quarters · filed 2012-10-25 | $70.38M 10-Q/A · filed 2012-10-25 | $81.18M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-09-01 | $33.60M 10-Q · filed 2012-10-23 | |||||
| 2011-06-30 | $20.42M 10-Q · filed 2012-07-25 | $36.78M 10-Q · filed 2012-07-25 | $47.58M derived: sum of 3 quarters · filed 2013-02-27 | $64.35M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2011-03-31 | $16.36M 10-Q · filed 2012-04-26 | $27.16M derived: sum of 2 quarters · filed 2013-02-27 | $43.93M derived: sum of 3 quarters · filed 2013-02-27 | $58.20M derived: sum of 4 quarters · filed 2013-02-27 | ||
| 2010-12-31 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $27.57M derived: sum of 2 quarters · filed 2013-02-27 | $41.84M derived: sum of 3 quarters · filed 2013-02-27 | $53.84M 10-K · filed 2013-02-27 | ||
| 2010-09-30 | $16.77M 10-Q · filed 2011-10-27 | $31.04M derived: sum of 2 quarters · filed 2011-10-27 | $43.04M 10-Q · filed 2011-10-27 | |||
| 2010-06-30 | $14.27M 10-Q · filed 2011-07-29 | $26.27M 10-Q · filed 2011-07-29 | ||||
| 2009-12-31 | $41.22M 10-K/A · filed 2012-03-19 |